Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-24 @ 11:43 PM
NCT ID:
NCT07266051
Eligibility Criteria:
Inclusion Criteria Inclusion Criteria for the NMOSD Patient Group
* Aged 18 years or older, regardless of sex
* Fulfilled the diagnostic criteria for Neuromyelitis Optica Spectrum Disorders as defined by the 2021 Chinese guidelines for the diagnosis and management of NMOSD
* Seropositive for AQP4-IgG
* Provided informed consent by the participant or their legal guardian
Inclusion Criteria for the Healthy Control Group
* Aged 18 years or older, regardless of sex
* Gender- and age-matched healthy individuals
* Provided informed consent by the participant or their legal guardian
Exclusion Criteria
* Diagnosis of other serious systemic diseases (e.g., malignancy)
* Presence of severe psychiatric disorders that would preclude compliance with study procedures and/or follow-up assessments
* History of infectious pathologies of the central nervous system
* Those with severe liver and kidney function impairment or dysfunction of other vital organs
* Patients with other conditions that do not allow participation in clinical research
* Patients allergic to gadolinium-DPTA
* Patients with other conditions that do not allow participation in clinical research
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07266051
Study Brief:
Protocol Section:
NCT07266051